Metformin use during COVID-19 infection and risk of developing Long COVID

Metformin prescribed within 6 days of SARS-CoV-2 infection may influence the risk of developing Long COVID.

• The analysis focuses on metformin as a potential intervention for Long COVID.
• Comparison is made with other medications: fluvoxamine, fluticasone, ivermectin, and montelukast.
• Data is drawn from electronic health records of new users of metformin and the experimental control drugs.
• The study evaluates the timing of medication prescription relative to the onset of infection.

Simplified